Lexston Life Sciences Corp. AI Stock Analysis
Want to see TSE:LEXT full AI Analyst Report?
Lexston Life Sciences Corp. (LEXT) AI Stock Analysis
Lexston Life Sciences Corp.
(CNQX:LEXT)
The overall score is the lowest possible, reflecting a company in severe financial distress. The most significant factor is the complete absence of revenue and persistent cash burn, which threatens the company's viability. This is compounded by a bearish technical trend with the stock price below all key moving averages. The debt-free balance sheet is the only mitigating factor, but it is insufficient to offset the fundamental operational and market weaknesses.
Lexston Life Sciences Corp. (LEXT) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 1.05M
- Dividend Yield
- ―
- Average Volume (3M)
- 39.88K
- Price to Earnings (P/E)
- -0.6
- Beta (1Y)
- 0.28
- Revenue Growth
- ―
- EPS Growth
- 71.78%
- Country
- Canada
- Employees
- 0
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Industrial Materials
Lexston Life Sciences Corp. Business Overview & Revenue Model
Company Description
Lexston Mining Corporation engages in the acquisition and exploration of mineral properties in Canada. The company holds a 100% interest in the Dory property located in the west of Port Alberni of British Columbia; and holds agreement of 100% interes...
Lexston Life Sciences Corp. Financial Statement Overview
Summary
Financial health is critically weak. The company is pre-revenue with a TTM net loss of $1.39M and negative operating cash flow of $1.09M. The only positive is a debt-free balance sheet, but equity is rapidly eroding, down 38% from 2022. This represents a highly speculative, high-risk financial profile.
Income Statement
1Very NegativeBalance Sheet
35NegativeCash Flow
10Very Negative| Breakdown | TTM | Aug 2026 | Aug 2025 | Aug 2024 | May 2023 | Aug 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 361.01K |
| Gross Profit | 0 | 0 | 0 | -26.39K | -29.80K | 241.49K |
| EBITDA | -1.35M | -1.35M | -1.51M | -648.32K | -841.73K | -2.29M |
| Net Income | -1.42M | -1.42M | -1.62M | -867.71K | -1.11M | -2.32M |
Balance Sheet | ||||||
| Total Assets | 891.25K | 891.25K | 279.49K | 750.95K | 814.30K | 952.80K |
| Cash, Cash Equivalents and Short-Term Investments | 126.52K | 126.52K | 2,322 | 390.40K | 511.00K | 590.49K |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 149.23K | 149.23K | 208.82K | 39.87K | 11.21K | 79.09K |
| Stockholders Equity | 742.02K | 742.02K | 70.67K | 711.08K | 803.10K | 873.71K |
Cash Flow | ||||||
| Free Cash Flow | -1.10M | -1.10M | -1.19M | -723.16K | -987.74K | -1.40M |
| Operating Cash Flow | -1.10M | -1.10M | -1.19M | -523.18K | -987.74K | -1.40M |
| Investing Cash Flow | -61.26K | -61.26K | -10.00K | -199.99K | 0 | -109.97K |
| Financing Cash Flow | 1.29M | 1.29M | 814.66K | 602.57K | 908.24K | 1.15M |
Lexston Life Sciences Corp. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LEXT, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.05, and below the 200-day MA of 0.07, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 41.93 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LEXT.
Lexston Life Sciences Corp. Peers Comparison
Overall Rating
TSE:LCR39Underperform- TSE:LEXT37Underperform
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:LEXT | Lexston Life Sciences Corp. | 0.04 | -0.27 | -87.10% | |
| TSE:LSD.H | Lightspeed Discoveries Inc. | 0.04 | 0.01 | 40.00% | |
| TSE:LCR | NeonMind Biosciences Inc | 0.01 | -0.03 | -75.00% |
Lexston Life Sciences Corp. Corporate Events
Lexston Mining Grants Stock Options to Bolster Exploration-Stage Growth
PositiveLexston Mining Corporation, a Canadian mineral explorer with projects in British Columbia and Nevada and acquisition plans in Guyana, focuses on building value through the advancement of its mineral portfolio. The company is listed on the Canadian Se...
Lexston Mining Shareholders Back Board, Auditor and Stock Option Plan at AGM
PositiveLexston Mining Corporation reported that shareholders approved all matters at its annual general and special meeting held on September 15, 2026. Investors confirmed the board size at four directors, re-elected Jagdip Bal, Jatinder J. Manhas, Clinton...
Lexston Mining Grants Stock Options to Align Stakeholder Interests
PositiveLexston Mining Corporation has granted incentive stock options to directors, officers and consultants to purchase up to 650,000 common shares at an exercise price of $0.08 per share for a period of five years. The options and any shares issued upon e...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 24, 2026